Cargando…
The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma
Pancreatic adenocarcinoma (PAAD) is the most malignant cancer with a high mortality rate. Despite the association of ribosomal protein L10 (RPL10) with PAAD and previous reports on RPL26 ufmylation, the relationship between RPL10 ufmylation and PAAD development remains unexplored. Here, we report th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244432/ https://www.ncbi.nlm.nih.gov/pubmed/37280198 http://dx.doi.org/10.1038/s41419-023-05877-y |
_version_ | 1785054638855159808 |
---|---|
author | Wang, Kun Chen, Siyu Wu, Yue Wang, Yang Lu, Yousheng Sun, Yanzi Chen, Yijun |
author_facet | Wang, Kun Chen, Siyu Wu, Yue Wang, Yang Lu, Yousheng Sun, Yanzi Chen, Yijun |
author_sort | Wang, Kun |
collection | PubMed |
description | Pancreatic adenocarcinoma (PAAD) is the most malignant cancer with a high mortality rate. Despite the association of ribosomal protein L10 (RPL10) with PAAD and previous reports on RPL26 ufmylation, the relationship between RPL10 ufmylation and PAAD development remains unexplored. Here, we report the dissection of ufmylating process of RPL10 and potential roles of RPL10 ufmylation in PAAD development. The ufmylation of RPL10 was confirmed in both pancreatic patient tissues and cell lines, and specific modification sites were identified and verified. Phenotypically, RPL10 ufmylation significantly increased cell proliferation and stemness, which is principally resulted from higher expression of transcription factor KLF4. Moreover, the mutagenesis of ufmylation sites in RPL10 further demonstrated the connection of RPL10 ufmylation with cell proliferation and stemness. Collectively, this study reveals that PRL10 ufmylation plays an important role to enhance the stemness of pancreatic cancer cells for PAAD development. |
format | Online Article Text |
id | pubmed-10244432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102444322023-06-08 The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma Wang, Kun Chen, Siyu Wu, Yue Wang, Yang Lu, Yousheng Sun, Yanzi Chen, Yijun Cell Death Dis Article Pancreatic adenocarcinoma (PAAD) is the most malignant cancer with a high mortality rate. Despite the association of ribosomal protein L10 (RPL10) with PAAD and previous reports on RPL26 ufmylation, the relationship between RPL10 ufmylation and PAAD development remains unexplored. Here, we report the dissection of ufmylating process of RPL10 and potential roles of RPL10 ufmylation in PAAD development. The ufmylation of RPL10 was confirmed in both pancreatic patient tissues and cell lines, and specific modification sites were identified and verified. Phenotypically, RPL10 ufmylation significantly increased cell proliferation and stemness, which is principally resulted from higher expression of transcription factor KLF4. Moreover, the mutagenesis of ufmylation sites in RPL10 further demonstrated the connection of RPL10 ufmylation with cell proliferation and stemness. Collectively, this study reveals that PRL10 ufmylation plays an important role to enhance the stemness of pancreatic cancer cells for PAAD development. Nature Publishing Group UK 2023-06-07 /pmc/articles/PMC10244432/ /pubmed/37280198 http://dx.doi.org/10.1038/s41419-023-05877-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wang, Kun Chen, Siyu Wu, Yue Wang, Yang Lu, Yousheng Sun, Yanzi Chen, Yijun The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma |
title | The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma |
title_full | The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma |
title_fullStr | The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma |
title_full_unstemmed | The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma |
title_short | The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma |
title_sort | ufmylation modification of ribosomal protein l10 in the development of pancreatic adenocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244432/ https://www.ncbi.nlm.nih.gov/pubmed/37280198 http://dx.doi.org/10.1038/s41419-023-05877-y |
work_keys_str_mv | AT wangkun theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT chensiyu theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT wuyue theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT wangyang theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT luyousheng theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT sunyanzi theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT chenyijun theufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT wangkun ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT chensiyu ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT wuyue ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT wangyang ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT luyousheng ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT sunyanzi ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma AT chenyijun ufmylationmodificationofribosomalproteinl10inthedevelopmentofpancreaticadenocarcinoma |